NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER,申请号CA19962189501-传众专利搜索

发明名称	NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER
摘要	The present invention relates to the use of certain NK-1 receptor antagonists (e.g., substance P receptor antagonists) to treat cancer patients, particularly cancer patients afflicted with a small cell lung carcinoma, APUDoma, astrocytoma, neuroendocrine tumor or extrapulmonary small cell carcinoma.
申请公布号	CA2189501(A1)	申请公布日期	1997.05.07
申请号	CA19962189501	申请日期	1996.11.04
申请人	PFIZER INC.	发明人	HOWARD, HARRY R.
分类号	A61K31/435;C07D487/08;A61K31/439;A61K31/4427;A61K31/4433;A61K31/445;A61K31/4458;A61K31/47;A61P35/00;A61P43/00;C07D207/14;C07D211/56;C07D261/20;C07D263/56;C07D401/06;C07D401/12;C07D409/04;C07D417/12;C07D453/02;C07D471/08;(IPC1-7):A61K31/435	主分类号	A61K31/435
代理机构		代理人
主权项
地址